Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
23/03/2026
New York silver futures rose 1% intraday, now trading at $70.38 per ounce.
Latest
4 m ago
Commander of the Islamic Revolutionary Guard Corps Aerospace Force: The battle will continue until the national and patriotic goals are achieved.
5 m ago
Google's Wing will begin drone delivery service in the San Francisco Bay Area.
7 m ago
Market news: The French government has requested oil refining companies to increase production.
8 m ago
Sanhuan Group clarifies: rumors about media reports predicting a net loss in 2025 are not true.
12 m ago
According to the AI fast news, Huayuan Securities released a research report on March 23, giving Junshi Biosciences (688180.SH) a "buy" rating. The reasons for the rating include: 1) a well-known domestic innovative pharmaceutical company with a solid business foundation; 2) strong innovative pipeline strength, with the late-stage pipeline expected to gradually enter the realization period; 3) a differentiated early research pipeline with promising future prospects. (Daily Economic News)
See all latest